Paola Portillo Sanchez
Overview
Explore the profile of Paola Portillo Sanchez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Hecht J, Tio F, et al.
J Clin Endocrinol Metab
. 2017 Jun;
102(8):2950-2961.
PMID: 28575232
Context: Patients with nonalcoholic fatty liver disease have a high cardiovascular risk, but statins are rarely prescribed because of fear of hepatotoxicity. Objective: To prospectively assess the long-term safety of...
2.
Bril F, Kadiyala S, Portillo Sanchez P, Sunny N, Biernacki D, Maximos M, et al.
J Investig Med
. 2016 Jan;
64(1):63-8.
PMID: 26755815
The underlying mechanisms responsible for the development and progression of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM) are unclear. Since the thyroid hormone regulates...
3.
Bril F, Sninsky J, Baca A, Superko H, Portillo Sanchez P, Biernacki D, et al.
J Clin Endocrinol Metab
. 2015 Dec;
101(2):644-52.
PMID: 26672634
Context: Patients with nonalcoholic fatty liver disease (NAFLD) are at increased risk of cardiovascular disease, and atherogenic lipoproteins may play an important role. Objective: The objective of the study was...
4.
Portillo Sanchez P, Bril F, Maximos M, Lomonaco R, Biernacki D, Orsak B, et al.
J Clin Endocrinol Metab
. 2014 Oct;
100(5).
PMID: 25303488
Context And Objective: NAFLD, and its more severe form with steatohepatitis (NASH), are common in patients with T2DM. However, they are usually believed to affect largely those with elevated aminotransferases....
5.
Kawaguchi-Suzuki M, Bril F, Portillo Sanchez P, Cusi K, Frye R
J Chromatogr B Analyt Technol Biomed Life Sci
. 2014 Sep;
969:219-23.
PMID: 25195022
A simple and rapid high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed for the simultaneous determination of pioglitazone and its active metabolites hydroxypioglitazone and ketopioglitazone in human plasma....
6.
Maximos M, Bril F, Portillo Sanchez P, Lomonaco R, Orsak B, Biernacki D, et al.
Hepatology
. 2014 Aug;
61(1):153-60.
PMID: 25145475
Unlabelled: Plasma aminotransferases (aspartate aminotransferase [AST] and alanine aminotransferase [ALT]) are usually increased in patients with nonalcoholic fatty liver disease (NAFLD). However, the factors behind their elevation remain unclear. The...